- Home
- Publications
- Publication Search
- Publication Details
Title
Leishmaniasis: treatment, drug resistance and emerging therapies
Authors
Keywords
-
Journal
Expert Opinion on Orphan Drugs
Volume 7, Issue 1, Pages 1-10
Publisher
Informa UK Limited
Online
2018-12-05
DOI
10.1080/21678707.2019.1552853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of miltefosine monotherapy and pentoxifylline associated with pentavalent antimony in treating mucosal leishmaniasis
- (2018) Fernanda Ventin et al. Expert Review of Anti-Infective Therapy
- In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis
- (2018) Sara Teixeira de Macedo Silva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by Leishmania major
- (2018) Felipe Rodriguez et al. MOLECULES
- A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia
- (2018) Liliana López et al. PLoS Neglected Tropical Diseases
- Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
- (2017) Saumya Srivastava et al. Parasites & Vectors
- Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
- (2017) Ridwanur Rahman et al. PLoS Neglected Tropical Diseases
- Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
- (2017) Sarah Hendrickx et al. PLoS Neglected Tropical Diseases
- Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
- (2017) Gustavo Adolfo Sierra Romero et al. PLoS Neglected Tropical Diseases
- Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
- (2017) Alicia Ponte-Sucre et al. PLoS Neglected Tropical Diseases
- Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
- (2016) Aschalew Tamiru et al. BMC INFECTIOUS DISEASES
- New approaches from nanomedicine for treating leishmaniasis
- (2016) Víctor Gutiérrez et al. CHEMICAL SOCIETY REVIEWS
- Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness inLeishmania infantum
- (2016) S. Hendrickx et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
- (2016) Gloria Morizot et al. PLoS Neglected Tropical Diseases
- Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
- (2016) Monique Wasunna et al. PLoS Neglected Tropical Diseases
- HIV and Visceral Leishmaniasis Coinfection in Bihar, India: An Underrecognized and Underdiagnosed Threat Against Elimination
- (2014) Sakib Burza et al. CLINICAL INFECTIOUS DISEASES
- Investigational drugs for visceral leishmaniasis
- (2014) Shyam Sundar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- An update on pharmacotherapy for leishmaniasis
- (2014) Shyam Sundar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Carbon nanotube based betulin formulation shows better efficacy against Leishmania parasite
- (2014) Prakash Saudagar et al. PARASITOLOGY INTERNATIONAL
- Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia
- (2014) Bart Ostyn et al. PLoS One
- Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients
- (2014) C. Rocio et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India
- (2014) Sakib Burza et al. PLoS Neglected Tropical Diseases
- Leishmania-HIV Co-infection: Clinical Presentation and Outcomes in an Urban Area in Brazil
- (2014) Gláucia F. Cota et al. PLoS Neglected Tropical Diseases
- High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
- (2014) Ermias Diro et al. PLoS Neglected Tropical Diseases
- Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
- (2013) Suman Rijal et al. CLINICAL INFECTIOUS DISEASES
- Strategies for the design of orally bioavailable antileishmanial treatments
- (2013) T.T.H. Pham et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Relapse after Treatment with Miltefosine for Visceral Leishmaniasis Is Associated with Increased Infectivity of the Infecting Leishmania donovani Strain
- (2013) K. Rai et al. mBio
- Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use
- (2012) S. Sundar et al. CLINICAL INFECTIOUS DISEASES
- Leishmaniasis: an update of current pharmacotherapy
- (2012) Shyam Sundar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
- (2012) T. P. C. Dorlo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?
- (2012) Lucio H. Freitas-Junior et al. International Journal for Parasitology-Drugs and Drug Resistance
- Can We Use a Lower Dose of Liposomal Amphotericin B for the Treatment of Mucosal American Leishmaniasis?
- (2011) Valdir S. Amato et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Phase IV Trial of Miltefosine in Adults and Children for Treatment of Visceral Leishmaniasis (Kala-Azar) in Bangladesh
- (2011) Mahmudur Rahman et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2011) Bidyut Purkait et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis
- (2011) V. Ramesh et al. BRITISH JOURNAL OF DERMATOLOGY
- Limited Effectiveness of High-Dose Liposomal Amphotericin B (AmBisome) for Treatment of Visceral Leishmaniasis in an Ethiopian Population With High HIV Prevalence
- (2011) K. Ritmeijer et al. CLINICAL INFECTIOUS DISEASES
- Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
- (2011) Shane R. Wilkinson et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Recent advances in leishmaniasis treatment
- (2011) Tatiana S. Tiuman et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Unusual Case of Resistance to Amphotericin B in Visceral Leishmaniasis in a Region in India Where Leishmaniasis Is Not Endemic
- (2011) P. Srivastava et al. JOURNAL OF CLINICAL MICROBIOLOGY
- An Oral Formulation of Amphotericin B Attached to Functionalized Carbon Nanotubes Is an Effective Treatment for Experimental Visceral Leishmaniasis
- (2011) Vijay Kumar Prajapati et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica
- (2010) M. Solomon et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
- (2010) Shyam Sundar et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors
- (2009) Michael B. Jameson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials
- (2009) Dae Hyun Kim et al. PLoS Neglected Tropical Diseases
- New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine
- (2008) Shyam Sundar et al. CLINICAL INFECTIOUS DISEASES
- The Relationship between Leishmaniasis and AIDS: the Second 10 Years
- (2008) J. Alvar et al. CLINICAL MICROBIOLOGY REVIEWS
- Design of anticancer prodrugs for reductive activation
- (2008) Yu Chen et al. MEDICINAL RESEARCH REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started